MetLife Investment Management’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$747K Sell
29,876
-224
-0.7% -$6.31K ﹤0.01% 1553
2025
Q4
$947K Sell
30,100
-1,344
-4% -$44.6K ﹤0.01% 1460
2025
Q3
$1.12M Hold
31,444
0.01% 1372
2025
Q2
$1.81M Buy
31,444
+5,114
+19% +$289K 0.01% 1038
2025
Q1
$1.53M Sell
26,330
-350
-1% -$23.9K 0.01% 1165
2024
Q4
$2.15M Buy
26,680
+2,144
+9% +$183K 0.01% 998
2024
Q3
$1.97M Hold
24,536
0.01% 1025
2024
Q2
$1.5M Buy
24,536
+4,060
+20% +$241K 0.01% 1124
2024
Q1
$1.01M Sell
20,476
-860
-4% -$40.9K 0.01% 1294
2023
Q4
$894K Buy
21,336
+2,142
+11% +$72.9K 0.01% 1358
2023
Q3
$630K Hold
19,194
﹤0.01% 1483
2023
Q2
$679K Buy
19,194
+5,396
+39% +$178K ﹤0.01% 1494
2023
Q1
$392K Hold
13,798
﹤0.01% 1797
2022
Q4
$573K Hold
13,798
﹤0.01% 1557
2022
Q3
$572K Hold
13,798
﹤0.01% 1544
2022
Q2
$451K Buy
13,798
+8,790
+176% +$320K ﹤0.01% 1732
2022
Q1
$175K Buy
+5,008
New +$121K ﹤0.01% 2435

Other funds holding PRCT